Neurobiology of hypoxic-ischemic injury in the developing brain

Pediatric Research

Volumn 49, Issue 6, 2001, Pages 735-741

  Johnston, Michael V ^a,c   Trescher, William H ^a   Ishida, Akira ^b   Nakajima, Wako ^b   Zipursky, Alvin ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KENNEDY KRIEGER INSTITUTE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

BRAIN DEVELOPMENT; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CEREBRAL PALSY; HISTOPATHOLOGY; HUMAN; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; NEUROTRANSMISSION; PRIORITY JOURNAL; REVIEW;

EID: 0034991340     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200106000-00003     Document Type: Review

References (101)

1. Experimental biology of cerebral hypoxia-ischemia: Relation to perinatal brain damage
2. Novel treatments after experimental brain injury
3. The role of glutamate neurotoxicity in hypoxicischemic neuronal death
4. Hypoxic and ischemic central nervous system disorders in infants and children
5. NBQX alternates excitotoxic injury in developing white matter
6. VIP neuroprotection against excitotoxic lesions in developing mouse brain
7. Neonatal encephalopathy following fetal distress: A clinical and electroencephalographic study
8. Temporal evolution of neuropathologic changes in an immature animal model of cerebral hypoxia: A light microscopic study
9. Unilateral hypoxic-ischemic injury in the neonatal rat brain evaluated by in vivo MRI
10. Outcome after ischemia in the developing sheep brain: An electroencephalographic and histological study
11. MK-801 protects the neonatal brain from hypoxic-ischemic damage
12. Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat
13. Hypoxia-ischemia in the neonatal rat brain: Histopathology after post-treatment with NMDA and non-NMDA receptor antagonists
14. Selective vulnerability in the neonatal brain
15. Brain injury in the premature infant: Neuropathology, clinical aspects, and prevention
16. Hypoxic-ischemic brain injury in the term newborn: Neuropathology, clinical aspects, and neuroimaging
17. Clinical and MR correlates in children with extrapyramidal cerebral palsy
18. Perinatal asphyxia: MR findings in the first 10 days
19. Brain MRI in suspected extrapyramidal cerebral palsy: Observations in distinguishing genetic-metabolic from acquired causes
20. Perinatal hypoxic-ischemic thalamic injury: Clinical features and neuroimaging
21. The syndrome of near-total intrauterine asphyxia in the term infant
22. Rolandic-type cerebral palsy in children as a pattern of hypoxic-ischemic injury in the full-term neonate
23. Abnormal magnetic resonance signal in the internal capsule predicts poor neurodevelopmental outcome in infants with hypoxic-ischemic encephalopathy
24. Two patterns of brain damage and their conditions of occurrence
25. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development
26. Functional architectural of basal ganglia circuits: Neural substrates of parallel processing
27. Excitotoxic mechanisms of epileptic brain damage
28. Possible mechanisms for selective basal ganglia damage in infants from asphyxia, kernicterus, or mitochondrial encephalopathies
29. 18F]FDG positron emission tomography in infants with hypoxic-ischemic encephalopathy shows hypermetabolism during the postasphyctic period
30. NMDA-dependent increase of cerebral glucose utilization after hypoxia-ischemia in the immature rat
31. Energy on demand
32. Energetics of functional activation in neural tissues
33. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity
34. Evidence for coupling between glucose metabolism and glutamate cycling using FDG-PET and 1H magnetic resonance spectroscopy in patients with epilepsy
35. Intra- and extracellular changes of amino acids in the cerebral cortex of the neonatal rat during hypoxia-ischemia
36. Extracellular overflow of glutamate, aspartate, GABA, and taurine in the cortex and basal ganglia of fetal lambs during hypoxia-ischemia
37. Excitatory amino acids in cerebrospinal fluid in neonatal asphyxia
38. Hypoxia-ischemia stimulates hippocampal glutamate efflux in perinatal rat brain: An in vivo microdialysis study
39. Excitatory amino acids in the cerebral spinal fluid of asphyxiated infants: Relationship to hypoxic-ischemic encephalopathy
40. Increased detectability of alpha brain glutamate/glutamine in neonatal hypoxic-ischemic encephalopathy
41. 3H-glutamate uptake into synaptosomes
42. Excitotoxic brain injury suppresses striatal high affinity glutamate uptake in perinatal rats
43. Acute decrease in net glutamate uptake during energy deprivation
44. Glutamate release in severe brain ischemia is mainly by reversed uptake
45. Hypoxia-ischemia causes abnormalities in glutamate transport and death of astroglia and neurons in newborn striatum
46. Metabolic imaging: A window on brain development and plasticity
47. Mechanisms of cerebral injury in perinatal asphyxia and strategies for prevention
48. Glutamate becomes neurotoxic via the NMDA receptor when intracellular energy levels are reduced
49. Anoxic LTP sheds light on the multiple facets of NMDA receptors
50. Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system
51. Development and regional expression in the rat brain and functional properties of four NMDA receptors
52. + channels, glutamate release, and NMDA receptors mediates delayed neurodegeneration through nitric oxide formation
53. Nitric oxide in cerebral ischemic neurodegeneration and excitotoxicity
54. Nitric oxide mediates glutamate-induced mitochondrial depolarization in rat cortical neurons
55. Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury
56. Neuroprotective effects of N-nitro-L-arginine in focal stroke in the 7-day-old rat
57. L-NAME reduces infarct volume in a filament model of transient middle cerebral artery occlusion in the rat pup
58. Inhibitor of nitric oxide synthesis reduces hypoxic-ischemic brain damage in the neonatal rat
59. Inhibition of interleukin-1-beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage
60. Adenovirus-mediated over-expression of interleukin-1-beta receptor antagonist reduces susceptibility to excitotoxic brain injury in perinatal rats
61. Cytokines and perinatal brain injury
62. Interleukin-6 in the cerebrospinal fluid after perinatal asphyxia is related to early and late neurological manifestations
63. Enhanced expression of interleukin-1 (IL-1) and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats
64. Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function
65. Ischemic delayed neuronal death, a mitochondrial hypothesis
66. Mitochondrial function and energy metabolism after hypoxia-ischemia in the immature brain: Involvement of NMDA receptors
67. Glutamate becomes neurotoxic via NMDA receptors when intracellular energy levels are reduced
68. Persistent increases in cerebral lactate concentration after birth asphyxia
69. A piglet survival model of posthypoxic encephalopathy
70. Caspase inhibitor affords neuroprotection after delayed administration in a rat model of neonatal hypoxic-ischemic brain injury
71. Mechanisms underlying hypoxia-induced neuronal apoptosis
72. Poly(ADP-ribose)polymerase gene disruption renders mice resistant to cerebral ischemia
73. Apoptosis in the brains of infants suffering intrauterine cerebral injury
74. Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: Evidence for apoptosis during selective neuronal loss
75. Apoptosis in a neonatal rat model of cerebral hypoxia-ischemia
76. Apoptosis and necrosis in the newborn piglet brain following transient cerebral hypoxia-ischemia
77. Susceptibility to apoptosis is enhanced in immature conical neurons
78. Intact, injured, necrotic, and apoptotic cells after focal cerebral ischemia in the rat
79. Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat
80. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis
81. Apoptotic neurodegeneration following trauma is markedly enhanced in the immature brain
82. Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation
83. Synergistic effects of caspase inhibitors and MK-801 in brain injury, after transient focal cerebral ischemia in mice
84. Calpain inhibition: An overview of its therapeutic potential
85. The calpain proteolytic system in neonatal hypoxic-ischemia
86. The pharmacology of apoptosis
87. Caspases as treatment targets in stroke and neurodegenerative diseases
88. Marked age-dependent neuroprotection by BDNF against neonatal hypoxic-ischemic brain injury
89. Basic fibroblast growth factor protects against hypoxia-ischemia and NMDA neurotoxicity in neonatal rats
90. Human FGF-1 gene delivery protects against quinolinate-induced striatal and hippocampal injury in neonatal rats
91. Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lamb
92. Possible protective role of growth hormone in hypoxia-ischemia
93. Nerve growth factor protects the neonatal brain against hypoxic-ischemic injury
94. BDNF protects the neonatal brain from hypoxic-ischemic injury via the ERK pathway
95. Glucocorticoids and the prevention of hypoxic-ischemic brain damage
96. Brief post-hypoxic-ischemic hypothermia markedly delays neonatal brain injury
97. Effect of delayed MK-801 (dizocilpine) treatment with or without immediate postischemic hypothermia on chronic neuronal survival after global forebrain ischemia in rats
98. Protective effects of moderate hypothermia after neonatal hypoxia-ischemia: Short- and long-term outcome
99. Neuroprotection with prolonged head cooling started before postischemic seizures in fetal sheep
100. The window of opportunity for neuronal rescue with insulin-like growth factor-1 after hypoxia-ischemia in rats is critically modulated by cerebral temperatures during recovery
101. Nitric oxide mediates cerebral ischemic tolerance in a neonatal model of hypoxic preconditioning